Suraksha Diagnostic — 360° view

Suraksha Diagnostic, a company in the Healthcare Service Provider industry, reported revenue of ₹99 crore and net profit of ₹15 crore for the September 2026 quarter.

Suraksha Diagnostic (NSE: SURAKSHA) closed at ₹311.50 on 20 Nov 2026, up 3.4% over the past year. Its market capitalisation is ₹1,622 crore and it trades at 38.8 times earnings.

Share price
₹311.50 (20 Nov 2026)
Market cap
₹1,622 Cr (20 Nov 2026)
P/E
38.79 (20 Nov 2026)
Revenue
₹99 Cr (September 2026 quarter)
Net profit
₹15 Cr (September 2026 quarter)
ROCE
17.3% (FY26)
ROE
14.2% (FY26)
Book value
₹53.0 (FY26)
Dividend yield
0.16% (last 12 months to 20 Nov 2026)
52-week high / low
₹384.00 / ₹224.10 (20 Nov 2026)
1-year return
3.4% (to 20 Nov 2026)
Sector
Healthcare
Industry
Healthcare Service Provider
Symbol
NSE: SURAKSHA

Incorporated in 2005, Suraksha Diagnostic offers an integrated pathology, radiology testing, and medical consultancy services solution.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.